Show source-provided references
1. Hsu, C., Kwan, G., Thompson, S., Evans-Barns, H., and van Driel, M. (2012). Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst. Tev., 8.
10.1002/14651858.CD008017.pub3 ↗2. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V study
10.1007/s00270-009-9711-7 ↗3. (2007). Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N. Engl. J. Med., 356, 360–370.
10.1056/NEJMoa062003 ↗4. Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy—Results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial
10.1148/radiol.2463070260 ↗6. Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: Results of a limited randomized comparative study
10.1097/01.RVI.0000179793.69590.1A ↗7. (2009). Fatal nontarget embolization via an intrafibroid arterial venous fistula during uterine fibroid embolization. J. Vas. Interv. Radiol., 20, 419–420.
10.1016/j.jvir.2008.12.412 ↗12. Iodine-containing cellulose mixed esters as radiopaque polymers for direct embolization of cerebral aneurysms and arteriovenous malformations
10.1016/S0142-9612(01)00087-4 ↗13. In vitro assessment of EmboGel and UltraGel radiopaque hydrogels for the endovascular treatment of aneurysms
10.1016/j.jvir.2009.01.005 ↗18. Novel radiopaque embolic agent for uterine fibroid embolization: Determination of radiopacity and biological evaluation; cytocompatibility, intracutaneous reactivity and local effects after implantation
10.1016/j.jvir.2011.12.113 ↗19. Kehoe, S., Langman, M., Zwanziger, U.W., Abraham, R.J., and Boyd, D. Mixture designs to assess composition–structure–property relationships in SiO2–CaO–ZnO–La2O3–TiO2–MgO–SrO–Na2O glasses: Potential materials for embolization. Available online:http://www.ncbi.nlm.nih.gov/pubmed/22863846.
20. (Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing within A Risk Management Process, 2009). Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing within A Risk Management Process.
21. (Biological Evaluation of Medical Devices—Part 14: Identification and Quantification of Degradation Products from Ceramics, 2001). Biological Evaluation of Medical Devices—Part 14: Identification and Quantification of Degradation Products from Ceramics.
22. A preclinical study of the safety and efficacy of occlusinTM 500 artificial embolization device in sheep
10.1007/s00270-011-0218-7 ↗24. Adsorption and relaxation kinetics of albumin and fibrinogen on hydrophobic surfaces: Single-species and competitive behavior
10.1021/la990089q ↗25. Protein attachment on aluminosilicates surface studied by XPS and FTIR spectroscopy
28. Composition-structure-property (Zn2+ and Ca2+ ion release) evaluation of Si–Na–Ca–Zn–Ce glasses: Potential components for nerve guidance conduits
10.1016/j.msec.2010.12.016 ↗30. Canine model of ischemic stroke with permanent middle cerebral artery occlusion: Clinical and histopathological findings
10.4142/jvs.2007.8.4.369 ↗36. Impact of uterine fibroid embolization with danazol alginate microsphere on ovarian function and subsequent pregnancy
40. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by X-ray crystallography
10.1074/jbc.274.8.4917 ↗41. Review of medical physiology
42. Calcium-dependent unmasking of active-center cysteine during activation of fibrin stabilizing factor
10.1021/bi00715a024 ↗43. Transformation of cellular factor-XIII into an active zymogen transglutaminase in thrombin-stimulated platelets
10.1055/s-0038-1653844 ↗50. Serum magnesium level; comparison between healthy and malnourished children
53. Magnesium and cardiovascular system
55. Dissolution behavior and bioactivity study of glass ceramic scaffolds in the system of CaO-P2O5-Na2O-ZnO prepared by sol-gel technique
10.1016/j.msec.2009.09.006 ↗59. The effect of ionic dissolution products of Ca-Sr-Na-Zn-Si bioactive glass on in vitro cytocompatibility
10.1007/s10856-010-4139-9 ↗61. In vitro measurement of conformational stability of fibrinogen adsorbed on siloxane
10.1021/bm040041d ↗62. Platelet-rich plasma and fibrin glue-coated bioactive ceramics enhance growth and differentiation of goat bone marrow-derived stem cells
10.1089/ten.tea.2008.0229 ↗